These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 26658169

  • 1. Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations.
    Guacci A, Chetta M, Rizzo F, Marchese G, De Filippo MR, Giurato G, Nassa G, Ravo M, Tarallo R, Rocco T, Operto FF, Weisz A, Coppola G.
    Seizure; 2016 Jan; 34():26-8. PubMed ID: 26658169
    [No Abstract] [Full Text] [Related]

  • 2. Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children.
    Suvichapanich S, Jittikoon J, Wichukchinda N, Kamchaisatian W, Visudtibhan A, Benjapopitak S, Nakornchai S, Manuyakorn W, Mahasirimongkol S.
    J Hum Genet; 2015 Aug; 60(8):413-7. PubMed ID: 25994870
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases.
    Di Meglio C, Lesca G, Villeneuve N, Lacoste C, Abidi A, Cacciagli P, Altuzarra C, Roubertie A, Afenjar A, Renaldo-Robin F, Isidor B, Gautier A, Husson M, Cances C, Metreau J, Laroche C, Chouchane M, Ville D, Marignier S, Rougeot C, Lebrun M, de Saint Martin A, Perez A, Riquet A, Badens C, Missirian C, Philip N, Chabrol B, Villard L, Milh M.
    Epilepsia; 2015 Dec; 56(12):1931-40. PubMed ID: 26514728
    [Abstract] [Full Text] [Related]

  • 5. Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation.
    Dilena R, Striano P, Traverso M, Viri M, Cristofori G, Tadini L, Barbieri S, Romeo A, Zara F.
    Brain Dev; 2016 Jan; 38(1):128-31. PubMed ID: 26212315
    [Abstract] [Full Text] [Related]

  • 6. Folinic acid responsive epilepsy in Ohtahara syndrome caused by STXBP1 mutation.
    Tso WW, Kwong AK, Fung CW, Wong VC.
    Pediatr Neurol; 2014 Feb; 50(2):177-80. PubMed ID: 24315539
    [Abstract] [Full Text] [Related]

  • 7. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
    Kousar S, Wafai ZA, Wani MA, Jan TR, Andrabi KI.
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):504-16. PubMed ID: 25943175
    [Abstract] [Full Text] [Related]

  • 8. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Franco V, Perucca E.
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(8):1269-79. PubMed ID: 26037375
    [Abstract] [Full Text] [Related]

  • 9. Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients.
    Thakkar AN, Bendkhale SR, Taur SR, Gogtay NJ, Thatte UM.
    Neurol India; 2012 Jul; 60(6):577-80. PubMed ID: 23287317
    [Abstract] [Full Text] [Related]

  • 10. [Successful treatment with levetiracetam in a case of Ohtahara syndrome caused by STXBP1 mutation].
    Yamashita S, Chiyonobu T, Yoshida M, Moroto M, Morita T, Morioka S, Kato M, Saitsu H, Morimoto M, Hosoi H.
    No To Hattatsu; 2013 Jan; 45(1):64-6. PubMed ID: 23593750
    [No Abstract] [Full Text] [Related]

  • 11. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.
    Chaudhary N, Kabra M, Gulati S, Gupta YK, Pandey RM, Bhatia BD.
    BMC Pediatr; 2016 May 14; 16():66. PubMed ID: 27179628
    [Abstract] [Full Text] [Related]

  • 12. A novel mutation in STXBP1 gene in a child with epileptic encephalopathy and an atypical electroclinical pattern.
    Romaniello R, Zucca C, Tenderini E, Arrigoni F, Ragona F, Zorzi G, Bassi MT, Borgatti R.
    J Child Neurol; 2014 Feb 14; 29(2):249-53. PubMed ID: 24170257
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.
    Twardowschy CA, Werneck LC, Scola RH, De Paola L, Silvado CE.
    Arq Neuropsiquiatr; 2011 Apr 14; 69(2A):153-8. PubMed ID: 21537551
    [Abstract] [Full Text] [Related]

  • 16. STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy.
    Stamberger H, Nikanorova M, Willemsen MH, Accorsi P, Angriman M, Baier H, Benkel-Herrenbrueck I, Benoit V, Budetta M, Caliebe A, Cantalupo G, Capovilla G, Casara G, Courage C, Deprez M, Destrée A, Dilena R, Erasmus CE, Fannemel M, Fjær R, Giordano L, Helbig KL, Heyne HO, Klepper J, Kluger GJ, Lederer D, Lodi M, Maier O, Merkenschlager A, Michelberger N, Minetti C, Muhle H, Phalin J, Ramsey K, Romeo A, Schallner J, Schanze I, Shinawi M, Sleegers K, Sterbova K, Syrbe S, Traverso M, Tzschach A, Uldall P, Van Coster R, Verhelst H, Viri M, Winter S, Wolff M, Zenker M, Zoccante L, De Jonghe P, Helbig I, Striano P, Lemke JR, Møller RS, Weckhuysen S.
    Neurology; 2016 Mar 08; 86(10):954-62. PubMed ID: 26865513
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
    Liao K, Liu Y, Ai CZ, Yu X, Li W.
    Int J Clin Pharmacol Ther; 2018 Jul 08; 56(7):337-346. PubMed ID: 29628024
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
    Odani A, Hashimoto Y, Otsuki Y, Uwai Y, Hattori H, Furusho K, Inui K.
    Clin Pharmacol Ther; 1997 Sep 08; 62(3):287-92. PubMed ID: 9333104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.